UK Markets open in 3 hrs 53 mins
  • NIKKEI 225

    29,649.85
    -101.76 (-0.34%)
     
  • HANG SENG

    28,834.48
    +337.23 (+1.18%)
     
  • CRUDE OIL

    60.62
    +0.44 (+0.73%)
     
  • GOLD FUTURES

    1,744.80
    -2.80 (-0.16%)
     
  • DOW

    33,677.27
    -68.13 (-0.20%)
     
  • BTC-GBP

    45,841.21
    +1,543.16 (+3.48%)
     
  • CMC Crypto 200

    1,358.58
    +64.59 (+4.99%)
     
  • Nasdaq

    13,996.10
    +146.10 (+1.05%)
     
  • ^FTAS

    3,939.31
    +5.42 (+0.14%)
     

Worldwide Biopsy Devices Industry to 2026 - Players Include Argon Medical Devices, B. Braun Melsungen & Boston Scientific Among Others

Research and Markets
·9-min read

Dublin, March 22, 2021 (GLOBE NEWSWIRE) -- The "Biopsy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global biopsy devices market reached a value of US$ 2.12 Billion in 2020. Biopsy devices refer to various equipment that are used for surgical extraction of tissues from an organ. They are utilized by surgeons, radiologists, cardiologists and other medical practitioners to diagnose the presence or extent of diseases that are cancerous or inflammatory in nature. Equipment such as aspiration needles, forceps and localization wires are some of the commonly used biopsy devices. These devices are used in MRI-guided, needle-based, core and vacuum-assisted biopsies of body parts, including the liver, lungs, kidneys and breasts. They find extensive applications across numerous healthcare institutions, such as medical clinics, diagnostic centres and hospitals.

The rising instances of chronic medical ailments, especially breast cancer, is one of the key factors driving the growth of the market. Furthermore, rising consumer awareness regarding the availability of diagnostic and screening procedures for chronic diseases is boosting the demand for integrated technologies such as stereotactic-guided biopsies. There is also a growing preference for minimally invasive (MI) biopsy procedures among patients across the globe. For instance, the MI breast biopsy technique (MIBT) eliminates the need for surgery for cancer diagnosis while preserving healthy tissues from damage caused by radiation. Additionally, various technological advancements, including the development of vacuum-assisted guns and smart biopsy systems that aid in distinguishing healthy cells from tumorous ones, are also favoring the market growth. Other factors, including the rapidly growing geriatric population, increasing healthcare expenditure and extensive research and development (R&D) activities, are projected to drive the market in the coming years. Looking forward, the publisher expects the biopsy devices market to reach a value of US$ 2.87 Billion by 2026, exhibiting a CAGR of 5.12% during 2021-2026.

Breakup by Procedure Type:

  • Surgical Biopsy

  • Needle Biopsy

Breakup by Product:

  • Biopsy Guidance Systems

  • Needle Based Biopsy Guns

  • Biopsy Needles

  • Biopsy Forceps

  • Others

Breakup by Application:

  • Breast Biopsy

  • Lung Biopsy

  • Colorectal Biopsy

  • Prostate Biopsy

  • Others

Breakup by Guidance Technique:

  • Ultrasound Guided Biopsy

  • Stereotactic Guided Biopsy

  • MRI Guided Biopsy

  • Others

Breakup by End-User:

  • Hospitals and Clinics

  • Academic and Research Institutes

  • Others

Breakup by Region:

  • North America

  • United States

  • Canada

  • Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Others

  • Europe

  • Germany

  • France

  • United Kingdom

  • Italy

  • Spain

  • Russia

  • Others

  • Latin America

  • Brazil

  • Mexico

  • Others

  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Argon Medical Devices Inc., B. Braun Melsungen, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Cook Group Incorporated, Danaher Corporation, Hologic Inc., Medtronic Inc., etc.

Key Questions Answered in This Report:

  • How has the global biopsy devices market performed so far and how will it perform in the coming years?

  • What are the key regional markets?

  • What has been the impact of COVID-19 on the global biopsy devices market?

  • What is the breakup of the market based on the procedural type?

  • What is the breakup of the market based on the product?

  • What is the breakup of the market based on the application?

  • What is the breakup of the market based on the guidance technique?

  • What is the breakup of the market based on the end-user?

  • What are the various stages in the value chain of the industry?

  • What are the key driving factors and challenges in the industry?

  • What is the structure of the global biopsy devices market and who are the key players?

  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Biopsy Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID 19
5.4 Market Forecast

6 Market Breakup by Procedure Type
6.1 Surgical Biopsy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Needle Biopsy
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Product
7.1 Biopsy Guidance Systems
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Needle Based Biopsy Guns
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biopsy Needles
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Biopsy Foreceps
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Application
8.1 Breast Biopsy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Biopsy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Biopsy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prostate Biopsy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Guidance Technique
9.1 Ultrasound-guided Biopsy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Stereotactic-guided Biopsy
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 MRI-guided Biopsy
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast

10 Market Breakup by End User
10.1 Hospitals and Clinics
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Academic and Research Institutes
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast

11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast

12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Argon Medical Devices Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 B. Braun Melsungen
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Becton, Dickinson and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Boston Scientific Corporation
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Cardinal Health Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Cook Group Incorporated
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Danaher Corporation
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Hologic, Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Medtronic, Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/cajmsj

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900